These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12063046)

  • 1. A novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1.
    Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
    Jpn J Ophthalmol; 2002; 46(3):336-40. PubMed ID: 12063046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel mutation of the type 1 optic atrophy(OPA1) gene in a Japanese family with OPA1].
    Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
    Nippon Ganka Gakkai Zasshi; 2002 Jul; 106(7):398-403. PubMed ID: 12187822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.
    Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
    Am J Ophthalmol; 2003 Feb; 135(2):256-7. PubMed ID: 12566046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations of the OPA1 gene in Chinese dominant optic atrophy.
    Yen MY; Wang AG; Lin YC; Fann MJ; Hsiao KJ
    Ophthalmology; 2010 Feb; 117(2):392-6.e1. PubMed ID: 19969356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.
    Hayashi T; Gekka T; Omoto S; Takeuchi T; Kitahara K
    Ophthalmic Res; 2005; 37(4):214-24. PubMed ID: 16006781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel heterozygous splice site OPA1 mutation causes exon 10 skipping in Japanese patients with dominant optic atrophy.
    Iida K; Ohkuma Y; Hayashi T; Katagiri S; Fujita T; Tsunoda K; Yamada H; Tsuneoka H
    Ophthalmic Genet; 2016 Sep; 37(3):354-6. PubMed ID: 26854526
    [No Abstract]   [Full Text] [Related]  

  • 7. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation.
    Kamakari S; Koutsodontis G; Tsilimbaris M; Fitsios A; Chrousos G
    Mol Vis; 2014; 20():691-703. PubMed ID: 24883014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
    Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.
    Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H
    Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.
    Hamahata T; Fujimaki T; Fujiki K; Miyazaki A; Mizota A; Murakami A
    Jpn J Ophthalmol; 2012 Jan; 56(1):91-7. PubMed ID: 22042570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy.
    Nakamura M; Lin J; Ueno S; Asaoka R; Hirai T; Hotta Y; Miyake Y; Terasaki H
    Ophthalmology; 2006 Mar; 113(3):483-488.e1. PubMed ID: 16513463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two novel OPA1 mutations in Chinese families with autosomal dominant optic atrophy.
    Li Y; Deng T; Tong Y; Peng S; Dong B; He D
    Mol Vis; 2008; 14():2451-7. PubMed ID: 19112530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation of the OPA1 gene in a Japanese patient with autosomal dominant optic atrophy.
    Ban Y; Yoshida Y; Kawasaki S; Mochida C
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1581-3. PubMed ID: 17579882
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.
    Bolognini R; Gerth-Kahlert C; Abegg M; Bartholdi D; Mathis N; Sturm V; Gallati S; Schaller A
    BMC Med Genet; 2017 Feb; 18(1):22. PubMed ID: 28245802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant optic atrophy: correlation between clinical and molecular genetic studies.
    Puomila A; Huoponen K; Mäntyjärvi M; Hämäläinen P; Paananen R; Sankila EM; Savontaus ML; Somer M; Nikoskelainen E
    Acta Ophthalmol Scand; 2005 Jun; 83(3):337-46. PubMed ID: 15948788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy.
    Gallus GN; Cardaioli E; Rufa A; Da Pozzo P; Bianchi S; D'Eramo C; Collura M; Tumino M; Pavone L; Federico A
    Mol Vis; 2010 Feb; 16():178-83. PubMed ID: 20157369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant optic atrophy in a Japanese family with OPA1 frameshift mutation (V942fsX966).
    Hayashi T; Takeuchi T; Gekka T; Kitahara K
    Eur J Ophthalmol; 2007; 17(2):253-8. PubMed ID: 17415700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.
    Cohen L; Tzur S; Goldenberg-Cohen N; Bormans C; Behar DM; Reinstein E
    Genet Res (Camb); 2016 Jun; 98():e10. PubMed ID: 27265430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.